Cargando…
Is there a role for combination anti-remodelling therapy for heart failure secondary to chronic rheumatic mitral regurgitation?
INTRODUCTION: The value of combination anti-remodelling therapy for heart failure (HF) secondary to mitral regurgitation (MR) is unknown. We studied the effect of anti-remodelling therapy on clinical and echocardiographic parameters in patients with severe chronic rheumatic mitral regurgitation (CRM...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Clinics Cardive Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730678/ https://www.ncbi.nlm.nih.gov/pubmed/29144532 http://dx.doi.org/10.5830/CVJA-2016-095 |